Schraufnagel, Dean E.

Cyclophosphamide versus placebo in scleroderma lung disease

Tashkin, D. P., Elashoff, R., Clements, P. J., Goldin, J., Roth, M. D., Furst, D. E., Arriola, E., Silver, R., Strange, C., Bolster, M., et al. (2006) · New England Journal of Medicine

Systemic Sclerosis and Related DiseasesInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Cited by 1,677

Climate change and respiratory infections

Mirsaeidi, M., Motahari, H., Taghizadeh Khamesi, M., Sharifi, A., Campos, M., & Schraufnagel, D. E. (2016) · Annals of the American Thoracic Society

Climate Change and Health ImpactsAir Quality and Health Impacts

Cited by 228

Echocardiographic Markers of Elevated Pulmonary Pressure and Left Ventricular Diastolic Dysfunction Are Associated With Exercise Intolerance in Adults and Adolescents With Homozygous Sickle Cell Anemia in the United States and United Kingdom

Sachdev, V., Kato, G. J., Gibbs, J. S. R., Barst, R. J., Machado, R. F., Nouraie, M., Hassell, K. L., Little, J. A., Schraufnagel, D. E., Krishnamurti, L., et al. (2011) · Circulation

Hemoglobinopathies and Related DisordersPulmonary Hypertension Research and Treatments

Cited by 147

Risk Factors for Death in 632 Patients with Sickle Cell Disease in the United States and United Kingdom

Gladwin, M. T., Barst, R. J., Gibbs, J. S. R., Hildesheim, M., Sachdev, V., Nouraie, M., Hassell, K. L., Little, J. A., Schraufnagel, D. E., Krishnamurti, L., et al. (2014) · PLoS ONE

Hemoglobinopathies and Related DisordersPulmonary Hypertension Research and Treatments

Cited by 132